Following highly anticipated announcements, the FDA has authorized and recommended the Pfizer-BioNTech COVID-19 vaccine and Moderna’s mRNA vaccine for Emergency Use Authorization. Additionally, vaccines from AstraZeneca and Janssen (J&J) are currently in Phase 3 clinical trials or seeking FDA approval. More broadly, there are 52 vaccines currently in human clinical trials across the world. As COVID-19 vaccines continue to be authorized for use, many, if not all, COVID-19 vaccines will receive Emergency Use Authorization (EUA) approval. However, efficacy questions remain unanswered, some of which were not addressed in the initial clinical trials. With additional FDA EUA approval of COVID-19 vaccines on the immediate horizon, real-time vaccine updates will be the key to ensuring healthcare providers have verified and timely clinical data available.
In response to this critical conversation, GreenLight is launching COVID-19 Vaccines in the Product Research Library, built to support supply chain teams, clinicians, physicians, and pharmacy leaders through real-time vaccine updates and product education. As clinical evidence and clinical trial results evolve, vaccine profiles and content in the portal are updated continuously by the GreenLight Medical Research Team. GreenLight vaccine profiles include aggregated data on:
- Vaccine Descriptions
- Clinical Evidence
- FDA Regulatory Data
- Indications & Usage
- Recall & Adverse Events
- Therapeutic Equivalents
As part of GreenLight’s commitment to health systems and the larger healthcare ecosystem, we want to ensure access to GreenLight’s Product Research Library, where medical professionals can efficiently locate timely resources on COVID-19 vaccine research and efficacy data.
Please click here to request complimentary access today.